Potential new diagnostic test and treatment for lung cancer
July 18th, 2006
University of York spin out company, Cizzle Biotechnology, has secured venture capital funding from the White Rose Technology Seedcorn Fund to continue its development of a potential new diagnostic test and treatment for lung cancer.